标题
PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
作者
关键词
PRAME, PReferentially Antigen expressed in Melanoma, Triple negative breast cancer, Migration, Invasion, Epithelial-to-mesenchymal transition
出版物
Journal of Translational Medicine
Volume 17, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-01-03
DOI
10.1186/s12967-018-1757-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway
- (2018) Hanzhang Zhu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer
- (2018) Zhixian Liu et al. Translational Oncology
- NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
- (2018) Remy Thomas et al. Frontiers in Immunology
- Recent Advances in the Treatment of Breast Cancer
- (2018) Christy W. S. Tong et al. Frontiers in Oncology
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells
- (2017) Cornelia Siebenkäs et al. PLoS One
- PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma
- (2017) Gülçin Gezgin et al. JAMA Ophthalmology
- PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma
- (2016) M. G. Field et al. CLINICAL CANCER RESEARCH
- PRAME is critical for breast cancer growth and metastasis
- (2016) Zhengwang Sun et al. GENE
- The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients
- (2016) Sumitra Thongprasert et al. LUNG CANCER
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis
- (2016) Quan Huang et al. PLoS One
- Induction of WNT11 by hypoxia and hypoxia-inducible factor-1α regulates cell proliferation, migration and invasion
- (2016) Hiroyuki Mori et al. Scientific Reports
- Bone Morphogenetic Protein-7 Inhibits EMT-Associated Genes in Breast Cancer
- (2015) Xuexiang Ying et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Diagnostic marker signature for esophageal cancer from transcriptome analysis
- (2015) Ute Warnecke-Eberz et al. TUMOR BIOLOGY
- Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial Cells
- (2015) Christopher Dravis et al. Cell Reports
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Notch ligand Jagged1 as a target for anti-tumor therapy
- (2014) Demin Li Frontiers in Oncology
- Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?
- (2013) Miroslaw J Szczepanski et al. Biomarkers in Medicine
- Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
- (2013) H. Masuda et al. CLINICAL CANCER RESEARCH
- PRAME Gene Expression in Childhood Acute Lymphoblastic Leukemia: Impact on Prognosis
- (2013) Ca Abdelmalak et al. Clinical Laboratory
- PRAME/EZH2-Mediated Regulation of TRAIL: A New Target for Cancer Therapy
- (2013) D. D. De Carvalho et al. CURRENT MOLECULAR MEDICINE
- Knock-Down of PRAME Increases Retinoic Acid Signaling and Cytotoxic Drug Sensitivity of Hodgkin Lymphoma Cells
- (2013) Stefanie Kewitz et al. PLoS One
- Expression and prognostic relevance of PRAME in primary osteosarcoma
- (2012) Pingxian Tan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas
- (2012) Ashley Cimino-Mathews et al. HUMAN PATHOLOGY
- Global estimates of cancer prevalence for 27 sites in the adult population in 2008
- (2012) Freddie Bray et al. INTERNATIONAL JOURNAL OF CANCER
- Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment
- (2012) S. Gutierrez-Cosío et al. LEUKEMIA RESEARCH
- PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions
- (2012) Miroslaw J. Szczepanski et al. ORAL ONCOLOGY
- Epithelial-Mesenchymal Transition: General Principles and Pathological Relevance with Special Emphasis on the Role of Matrix Metalloproteinases
- (2012) P. Nistico et al. Cold Spring Harbor Perspectives in Biology
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells
- (2011) Norina Tanaka et al. LEUKEMIA RESEARCH
- -catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness
- (2011) E. Sanchez-Tillo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia
- (2010) Frances Wadelin et al. Molecular Cancer
- Aberrant hypomethylation of the cancer–testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia
- (2008) Christina A. Ortmann et al. ANNALS OF HEMATOLOGY
- PRAME expression and clinical outcome of breast cancer
- (2008) M T Epping et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started